First Data on Rivaroxaban for Cerebral Venous Thrombosis


Posted on: Sat 05-07-2014

 
Preliminary data suggest that the oral factor Xa inhibitor may have similar clinical benefit as vitamin K antagonists in the treatment of cerebral venous thrombosis.
 
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE : Final appraisal determination